Table 3.
Univariate and multivariable analysis of overall survival in lung adenocarcinoma from TCGA dataset
Variable | Univariate analysis | Multivariable analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P a | HR | 95% CI | P a | |
Gender | ||||||
Female | Reference | Reference | ||||
Male | 0.89 | 0.61‐1.29 | .5578 | 0.79 | 0.53‐1.16 | .2280 |
Age | ||||||
>65 years | Reference | Reference | ||||
≤65 years | 0.84 | 0.58‐1.22 | .3720 | 0.76 | 0.51‐1.13 | .1759 |
Smoking status | ||||||
Never smoker | Reference | Reference | ||||
Former smoker | 0.97 | 0.60‐1.63 | .8969 | 1.45 | 0.86‐2.53 | .1640 |
Current smoker | 0.69 | 0.37‐1.28 | .2342 | 0.76 | 0.40‐1.44 | .3966 |
Stage | ||||||
I | Reference | Reference | ||||
II | 2.64 | 1.63‐4.26 | <.0001 | 3.07 | 1.86‐5.07 | <0.0001 |
III | 4.42 | 2.74‐7.11 | <.0001 | 4.66 | 2.87‐7.56 | <0.0001 |
IV | 3.29 | 1.54‐6.40 | .0033 | 4.14 | 1.89‐8.31 | 0.0001 |
eIF2βmRNA expression | ||||||
Low | Reference | Reference | ||||
High | 1.96 | 1.07‐2.36 | .0225 | 1.61 | 1.06‐2.41 | .0255 |
P‐values were calculated by likelihood ratio test.